How does Baclofen Oral Granules work?

Baclofen oral granules, as aγ-aminobutyric acid (GABA) agonist, have demonstrated its unique clinical value in the field of neuroscience. For spastic symptoms caused by multiple sclerosis, such as flexor spasm, accompanying pain, clonus and muscle rigidity, Baclofen oral granules have become a new treatment option for many patients due to their significant efficacy.

Although the exact mechanism of action of baclofen has not yet been fully revealed by the scientific community, existing studies have shown that it may exert a therapeutic effect by inhibiting monosynaptic and polysynaptic reflexes at the spinal cord level. This inhibitory effect may be by reducing the release of excitatory neurotransmitters from afferent nerve terminals, thereby reducing the over-excitability state of neurons and achieving the purpose of relieving spasm. In addition, baclofen, as a structural analog of the inhibitory neurotransmitter GABA, may produce its clinical effects by stimulating GABA-B receptor subtypes.

The action and efficacy of Baclofen Oral Granules are based on rigorous scientific research and clinical trials. In a bioavailability study in healthy adults, baclofen oral granules were compared with baclofen oral tablets. The study results show that baclofen oral granules have general central nervous system depressant properties, which are manifested by the production of tolerance sedation, somnolence, ataxia, and respiratory and cardiovascular depression. These properties are the basis for baclofen to play a role in treating spasticity symptoms.

However, like all medicines, the use of baclofen oral granules is not without risks. Patients may encounter some side effects while taking it. Common side effects include drowsiness, dizziness, and weakness. These symptoms are usually more obvious early in the medication, but some patients may feel less severe as the body gradually adapts to the medication. However, serious side effects such as severe drowsiness, difficulty breathing, confusion, hallucinations, muscle weakness, itching, tingling, or twitching in the hands, arms, feet, or legs require patients to be highly vigilant. Once these symptoms occur, you should contact your doctor immediately for professional medical advice and treatment.

Therefore, when using baclofen oral granules, patients must strictly follow the doctor's instructions and take it in accordance with the prescribed dosage and usage. Do not increase or decrease the dose or stop the medication on your own to avoid affecting the efficacy or increasing the risk of side effects. At the same time, patients should also have regular follow-up visits so that doctors can keep abreast of changes in their condition and adjust treatment plans.

In summary, baclofen oral granules, as an effectiveGABA agonist, have demonstrated significant clinical efficacy in the treatment of spasticity symptoms caused by multiple sclerosis. However, its use also requires attention to side effects and risks. When using it, patients must fully understand the drug information and follow the doctor's instructions to ensure the safety and effectiveness of the treatment.

References:

https://www.drugs.com/newdrugs/fda-approves-lyvispah-baclofen-oral-granules-spasticity-5730.html